Immunotherapy in patients with early stage resectable nonsmall cell lung cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference16 articles.
1. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016
2. Early and locally advanced nonsmall cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2013
3. Local and systemic recurrence is the Achilles heel of cancer surgery;Aliperti;Ann Surge Oncol,2011
4. Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall cell lung cancer;Arriagada;N Engl J Med,2004
5. Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study;Kreuter;Ann Oncol,2013
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Advancements in Minimally Invasive Surgery for Early Stage Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2024-06-06
2. Single-cell sequencing on CD8+TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer;Journal for ImmunoTherapy of Cancer;2023-08
3. Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone;Frontiers in Oncology;2023-01-26
4. Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial;The Journal of Thoracic and Cardiovascular Surgery;2023-01
5. Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients;Frontiers in Immunology;2022-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3